A new molecular test could represent a big step forward in personalized diagnostics for non-infectious diseases like heart attacks and cancer.
Inspired by CRISPR technology, the new test, called CrisprZyme, was developed by a team of researchers led by Imperial College London, MIT, and Max Delbrück Center for Molecular Medicine in Berlin.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,